A
Alcista
Alcista · 25%ESTA
$56.20
Precio del escenario
$62.280
+1.233 (+1.98%)Al cierre
Loading chart…
- Máximo
- 63.400
- Apertura
- 61.500
- Precio medio ponderado por volumen
- 62.25
- Volumen
- 474.80K
- Capitalización
- 1.21B
- Mínimo
- 61.080
- Importe
- 29.56M
- EV/EBITDA, TTM
- -177.56
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Análisis de IA of Establishment Labs Holdings Inc (ESTA)
MantenerEstablishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.
Recomendaciones de analistas (3)
+33.08% de potencial alcista
Comprar
3 Comprar
0 Mantener
0 Vender
Actual: 62.28
Mínimo
75.00
Promedio
82.88
Máximo
90.00
Citi
Comprar
$92
2026-08-13
Citi
2026-08-13
Precio objetivo
$92
Comprar
Canaccord
Comprar
$105
2026-08-07
Canaccord
2026-08-07
Precio objetivo
$105
Comprar
Mizuho
Superar al mercado
$105
2026-07-15
Mizuho
2026-07-15
Precio objetivo
$105
Superar al mercado
Citi
Neutral
$92
2026-07-08
Citi
2026-07-08
Precio objetivo
$92
Neutral
BTIG
Comprar
$90
2026-05-07
BTIG
2026-05-07
Precio objetivo
$90
Comprar
Métricas de valoración
El PER previsto actual de Establishment Labs Holdings Inc (ESTA) es 204.08, frente a su media de 5 años de -19.89.
Escenarios de precio de Alphio AI para ESTA
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Ballenas con ESTA en cartera
Cronología de eventos
Noticias
6.010-15CNBCLatest Wall Street Rating Updates
8.510-05NewsfilterEstablishment Labs Receives FDA Approval for Expanded Breast Implant Range
- 8.509-21Newsfilter
Establishment Labs Presents New Clinical Data on Breast Tissue Preservation
8.509-02CNBCGLP-1 Drugs Boost Demand for Breast Augmentation
8.509-01PRnewswireGlobal Medical Aesthetics Market Poised for Significant Growth
Preguntas frecuentes sobre ESTA, respondidas por Alphio AI
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.
3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.